On the Couch with Scott Kirkland EM Vision Medical (EMV) - A Update on Progress

On the Couch

Welcome to the latest On the Couch. This occasional podcast series of chats with fund managers, CEO’s and brokers aims to give you an insight into the investing world. In this episode, I am joined by Scott Kirkland CEO and MD EM Vision (EMV).
Scott is the co-founder of EMVision (ASX:EMV). Scott has held several senior sales positions, including Head of Client Sales at Quantcast, a US-based technology company, prior to establishing EMVision as a leader in innovative neurodiagnostic technology.
In this episode we talk

• What EMV is trying to achieve?
• Why is it important?
• What progress have you made with emu and First Responder?
• How long do the trials take?
• When can we expect first revenue?
• How is the cash position?
• What are the milestones and catalysts for investors in the next 12 months?
• Why should investors buy EMV?

Disclaimer: This is general advice only and you should consult your financial adviser regarding any of the thoughts, ideas or insights in this podcast.
Why not sign up for a free trial? Get access to expert insights and research and become a better investor.
Subscribe now for in-depth market analysis, stock recommendations, investment and ideas strategies, and the suite of Marcus Today tools to manage your portfolio.